{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:18:53Z","timestamp":1789057133591,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2807,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011597","name":"Penn State Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011597","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.exphem.2014.07.261","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T11:18:46Z","timestamp":1405336726000},"page":"883-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways"],"prefix":"10.1016","volume":"42","author":[{"given":"Manoj K.","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay P.","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-shu","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Talamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Dovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantu G.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.07.261_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.261_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.exphem.2014.07.261_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11899-012-0135-0","article-title":"Prevention and treatment of myeloma bone disease","volume":"7","author":"Terpos","year":"2012","journal-title":"Curr Hematol Malign Rep"},{"key":"10.1016\/j.exphem.2014.07.261_bib4","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2012-10-435750","article-title":"Optimal use of bisphosphonates in patients with multiple myeloma","volume":"121","author":"Terpos","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.261_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nrc952","article-title":"Molecular mechanisms of novel therapeutic approaches for multiple myeloma","volume":"2","author":"Hideshima","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.07.261_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2014.07.261_bib7","first-page":"1329","article-title":"Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression","volume":"27","author":"Li","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.exphem.2014.07.261_bib8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.170.3.1136","article-title":"Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues","volume":"170","author":"Nakayama","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2014.07.261_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","article-title":"Role of chemokines in tumor growth","volume":"256","author":"Raman","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.exphem.2014.07.261_bib10","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.261_bib11","first-page":"539","article-title":"The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma","volume":"1","author":"Hideshima","year":"2002","journal-title":"Molec Canc Therapeu"},{"key":"10.1016\/j.exphem.2014.07.261_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2141.2007.06686.x","article-title":"Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity","volume":"138","author":"Trentin","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.07.261_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402717","article-title":"Expression and function of chemokine receptors in human multiple myeloma","volume":"17","author":"Moller","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.07.261_bib14","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood-2004-01-0272","article-title":"G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow","volume":"106","author":"Semerad","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.261_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00418-003-0587-3","article-title":"Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12","volume":"120","author":"Grassi","year":"2003","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.exphem.2014.07.261_bib16","first-page":"95","article-title":"Chemokines and chemokine receptors: their manifold roles in homeostasis and disease","volume":"1","author":"Le","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.exphem.2014.07.261_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bone.2005.01.021","article-title":"Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts","volume":"36","author":"Wright","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.exphem.2014.07.261_bib18","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-04-1687","article-title":"Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients","volume":"65","author":"Zannettino","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcp.10445","article-title":"CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients","volume":"199","author":"Grassi","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2014.07.261_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1359\/jbmr.090210","article-title":"Targeted disruption of the CXCL12\/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss","volume":"24","author":"Diamond","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/jor.22440","article-title":"CXCR4 antagonism attenuates load-induced periosteal bone formation in mice","volume":"31","author":"Leucht","year":"2013","journal-title":"J Orthop Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib22","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1182\/blood-2007-03-079616","article-title":"Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway","volume":"110","author":"Pandey","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.261_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1940-6207.CAPR-10-0340","article-title":"Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis","volume":"4","author":"Prasad","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.exphem.2014.07.261_bib24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1179\/joc.2009.21.6.666","article-title":"Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors","volume":"21","author":"Zhu","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.exphem.2014.07.261_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CEJ.0b013e328333fb22","article-title":"An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in\u00a0vitro","volume":"19","author":"Mu","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.exphem.2014.07.261_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2407-9-343","article-title":"The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma","volume":"9","author":"He","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2014.07.261_bib27","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00432-009-0624-2","article-title":"Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells","volume":"135","author":"Gu","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.exphem.2014.07.261_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-4632.2009.03946.x","article-title":"Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells","volume":"48","author":"Xu","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.exphem.2014.07.261_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/pmic.200800155","article-title":"Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma","volume":"9","author":"Wang","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.exphem.2014.07.261_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jep.2008.02.027","article-title":"Studies on the toxicity of gambogic acid in rats","volume":"117","author":"Qi","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.exphem.2014.07.261_bib31","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1248\/bpb.27.1769","article-title":"Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in\u00a0vivo and in\u00a0vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells","volume":"27","author":"Wu","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.exphem.2014.07.261_bib32","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.intimp.2008.05.013","article-title":"Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice","volume":"8","author":"Gu","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.exphem.2014.07.261_bib33","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/ijc.25868","article-title":"Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling","volume":"129","author":"Sung","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2014.07.261_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/hep.23748","article-title":"Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion","volume":"52","author":"Ding","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.exphem.2014.07.261_bib35","first-page":"200","article-title":"Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival","volume":"91","author":"Vande Broek","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.07.261_bib36","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2014.07.261_bib37","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2014.07.261_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007996124545","article-title":"Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes","volume":"11","author":"Eldridge","year":"1997","journal-title":"J Computer-Aided Molecul Des"},{"key":"10.1016\/j.exphem.2014.07.261_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exphem.2014.07.261_bib40","doi-asserted-by":"crossref","first-page":"45509","DOI":"10.1074\/jbc.C100527200","article-title":"Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting","volume":"276","author":"Marchese","year":"2001","journal-title":"J Bol Chem"},{"key":"10.1016\/j.exphem.2014.07.261_bib41","doi-asserted-by":"crossref","first-page":"36971","DOI":"10.1074\/jbc.M705085200","article-title":"Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4","volume":"282","author":"Bhandari","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.07.261_bib42","doi-asserted-by":"crossref","first-page":"21631","DOI":"10.1074\/jbc.M300609200","article-title":"NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4","volume":"278","author":"Helbig","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.07.261_bib43","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"Azab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.261_bib44","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib45","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.exphem.2014.07.261_bib46","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.07.261_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05018.x","article-title":"Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation","volume":"126","author":"Lai","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.07.261_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1006\/bbrc.1999.2008","article-title":"Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in\u00a0vitro","volume":"267","author":"Chikatsu","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2014.07.261_bib49","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.07.261_bib50","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.07.261_bib51","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/carcin\/bgn045","article-title":"Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells","volume":"29","author":"Tang","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.exphem.2014.07.261_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.onc.1206910","article-title":"Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells","volume":"23","author":"Fernandis","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.07.261_bib53","first-page":"6329","article-title":"Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation","volume":"62","author":"Gschwind","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20030267","article-title":"Regulation of the chemokine receptor CXCR4 by hypoxia","volume":"198","author":"Schioppa","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2014.07.261_bib55","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1158\/0008-5472.CAN-05-0957","article-title":"The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells","volume":"65","author":"Kulbe","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib56","first-page":"7203","article-title":"Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4","volume":"62","author":"Bachelder","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib57","first-page":"1215","article-title":"Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner","volume":"30","author":"Richard","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.exphem.2014.07.261_bib58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbrc.2010.11.018","article-title":"Gambogic acid inhibits Hsp90 and deregulates TNF-alpha\/NF-kappaB in HeLa cells","volume":"403","author":"Zhang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2014.07.261_bib59","first-page":"1299","article-title":"Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis","volume":"36","author":"Suzuki","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.exphem.2014.07.261_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/BJ20081482","article-title":"Gambogic acid covalently modifies IkappaB kinase-beta subunit to mediate suppression of lipopolysaccharide-induced activation of NF-kappaB in macrophages","volume":"419","author":"Palempalli","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2014.07.261_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00011-012-0563-2","article-title":"Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in\u00a0vivo and in\u00a0vitro","volume":"62","author":"Geng","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.22-1-65","article-title":"Mobilization of myeloma cells involves SDF-1\/CXCR4 signaling and downregulation of VLA-4","volume":"22","author":"Gazitt","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2014.07.261_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10585-007-9133-3","article-title":"Inhibition of the CXCR4\/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases","volume":"25","author":"Kim","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.exphem.2014.07.261_bib64","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.2003.18.8.1404","article-title":"Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration","volume":"18","author":"Yu","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.exphem.2014.07.261_bib65","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/14728214.8.2.469","article-title":"Bisphosphonate therapy in the oncology setting","volume":"8","author":"Lipton","year":"2003","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.exphem.2014.07.261_bib66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","article-title":"A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1400530X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1400530X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:31:56Z","timestamp":1759566716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1400530X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0301472X1400530X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.07.261","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.07.261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}